Skip to main content
  • Paul Scherrer Institut PSI
  • PSI Research, Labs & User Services

Digital User Office

  • Digital User Office
  • DE
  • EN
  • FR
Paul Scherrer Institut (PSI)
Suche
Paul Scherrer Institut (PSI)

Hauptnavigation

  • Our ResearchOpen mainmenu item
    • Current topics from our research
    • Matter and Material
    • Human Health
    • Energy and Environment
    • Large Research Facilities
    • Research on Covid-19
    • Brochures
    • 5232 — The magazine of the Paul Scherrer Institute
    • Research Divisions & Labs (only english)
  • IndustryOpen mainmenu item
    • Overview
    • Technology Transfer
    • Expertise
    • Spin-off Companies
    • Park Innovaare
  • Proton TherapyOpen mainmenu item
    • Overview
    • Physician & Patient Information
  • CareerOpen mainmenu item
    • Overview
    • Job Opportunities
    • Working at PSI
    • Personnel Policy
    • Equal Opportunities, Diversity & Inclusion
    • Training and Further Education
    • Vocational Training
    • PSI Education Centre
    • Career Center
    • Support Program "PSI Career Return Program"
    • PSI-FELLOW/COFUND
  • Visit to PSIOpen mainmenu item
    • Overview
    • Visitor Centre psi forum
    • Schülerlabor iLab
    • Public Events
    • How to find us
  • About PSIOpen mainmenu item
    • PSI in brief
    • Strategy
    • Guiding principles
    • Facts and figures
    • Organisational structure
    • For the media
    • Suppliers and customers
    • Customers E-Billing
  • DE
  • EN
  • FR

Digital User Office (mobile)

  • Digital User Office

You are here:

  1. PSI Home
  2. Our Research
  3. Research on Covid-19

Secondary navigation

Research on Covid-19

  • Useful links

  • Covid-19 page of the Photon Science Division
  • Call for submission of beamtime proposals
  • Offer for collaboration with other research groups
  • Covid-19 PSD/BIO

Research on Covid-19

The pandemic virus Covid-19
The pandemic virus Covid-19
(Photo: Alissa Eckert, MS, Dan Higgins, MAMS)

At PSI, several projects are dedicated to important research questions concerning the Sars-CoV-2 coronavirus and the resulting diseases. We provide information on activities and projects, for example on investigations of lung tissue, on the production of proteins and antibodies or on ideas for new research on Covid-19.

Further Information

24 January 2022
Thomas Mortelmans

New, better coronavirus rapid test

Media Releases Human Health Medical Science Research on Covid-19

The test identifies different virus variants and improves disease prognosis.

Read more
5 July 2021
Corona Dunkelziffer

Tracking down unreported Coronavirus cases

Research Using Synchrotron Light Biology Human Health Medical Science Research on Covid-19

The University Hospital of Zurich uses proteins made at PSI for Europe’s first large-scale serology study on coronavirus prevalence in Switzerland.

Read more
22 June 2021
 (Photo:Shutterstock.com)

PSI: advancing in the fight against Covid-19

Human Health Medical Science Research on Covid-19

Crystal structure analysis, computer models, cell cultures – to pursue research on Sars-CoV-2, PSI is exploring many avenues. An overview.

Read more
11 May 2021
Teaser Remdesivir

How remdesivir works against the coronavirus

Human Health Medical Science Research on Covid-19

Researchers at Goethe University Frankfurt, in cooperation with the PSI have probably discovered another, previously unknown mechanism of action of the antiviral remdesivir.

Read more
8 March 2021
Teaser covid research

Forschung zu Covid-19 am Paul Scherrer Institut

Forschung zu Covid-19

Während viele Bereiche des Lebens eingeschränkt sind, bleiben wichtige Forschungsanlagen am PSI in Betrieb. 

Read more
7 December 2020
Urs Baltensperger

The role of aerosols in the Coronavirus pandemic

Research on Covid-19

It now seems certain that Covid-19 can be transmitted via airborne particles. But how are these particles produced? How quickly can transmission occur and how can we protect ourselves? PSI aerosol researcher Urs Baltensperger summarises the most important facts on this issue.

Read more
31 August 2020
May Sharpe

A question of binding

Research Using Synchrotron Light Large Research Facilities Biology Human Health Research on Covid-19

At PSI, researchers are screening molecule fragments to see if these bind to important proteins of the coronavirus SARS-CoV-2 and thus have the potential to disable it. They are hoping the many individual pieces of information will yield an answer as to what an effective drug might look like.

Read more
6 August 2020
Prevot

Coronavirus advice: Ventilate, ventilate, ventilate!

Biology Human Health Research on Covid-19

SARS-CoV-2 might be transmitted via aerosols, that is, through the air. Researchers point this out in the journal Clinical Infectious Diseases. André Prévôt from PSI co-signed the publication. In this interview, he explains which precautionary measures he recommends.

Read more
30 July 2020
Dr. May Elizabeth Sharpe

Covid-19 research: Anti-viral strategy with double effect

Research Using Synchrotron Light Biology Human Health Research on Covid-19

Frankfurt scientists identify a possible weakness of the SARS-CoV-2 virus. They carried out part of their measurements at PSI's Swiss Light Source SLS. The research results are published this week in the scientific journal Nature.

Read more
9 April 2020
Teaser Luftbild

Priority research continues

Research on Covid-19

The Paul Scherrer Institute PSI is in limited operation due to the Covid-19 pandemic, and most employees are working from home in accordance with the Federal Council's specifications. Nevertheless, essential research facilities and projects continue to operate in accordance with all the necessary safety precautions.

Read more
9 April 2020
teaserbild.jpg

«Every day counts in the battle against the virus»

Research on Covid-19

The outbreak of the coronavirus pandemic has changed the way research is carried out at PSI but has not brought it to a standstill. Gabriel Aeppli, head of the Photon Science Division at PSI, talks about the exceptional threat that Covid-19 represents and how PSI researchers are studying this new virus at SLS, and possibly soon at SwissFEL as well.

Read more
9 April 2020
Teaser Nanowelten in 3-D

"We want to understand how this virus works"

Research on Covid-19

The Swiss Light Source SLS at PSI is still in operation despite the Covid-19 pandemic – and may be urgently needed, especially in these difficult times. Oliver Bunk, head of the Laboratory for Macromolecules and Bioimaging, explains why.

Read more
9 April 2020
Teaser Shivashankar

Why Covid-19 hits older people especially hard

Research on Covid-19

The older you are, the higher the risk of dying from a coronavirus infection. G. V. Shivashankar, a group leader at PSI and professor at ETH Zurich, now presents an unusual thesis in a publication in Nature Reviews: that the stiffness of cells might play a decisive role in the course of the disease. In this interview, he explains why.

Read more
9 April 2020
teaserbild_schertler.jpg

"Strategy and networking are enormously important"

Research on Covid-19

Gebhard Schertler, head of the Biology and Chemistry Division at PSI and professor of structural biology at ETH Zurich, explains what research is being done on the coronavirus at PSI and why collaboration with researchers from other institutions plays such an important role in this.

Read more
9 April 2020
Mirjam van Daalen im SwissFEL-Tunnel

«SLS is something very special right now, across Europe»

Research on Covid-19

The Swiss Light Source SLS is one of just a few facilities of its kind in Europe that are still in operation during these pandemic times. In an interview, Mirjam van Daalen, chief of staff of the Photon Science Division, emphasises how important international cooperation is these days.

Read more

Further information

For professionals only

  • Covid-19 page of the Photon Science Division
  • Offer for collaboration with other research groups
  • Call for submission of beamtime proposals
  • Covid-19 task force of the ETH Board
  • Covid-19 page of LEAPS
  • Covid-19 page of the light source community worldwide

Sidebar

5232_2-22_e.jpg

5232 — The magazine of the Paul Scherrer Institute

02/2022
View in issuu.com
Download
Subscribe to our magazine

Visitor Centre psi forum

Experience research live


The iLab School Laboratory

Experience Science - Explore Research

top

Footer

Paul Scherrer Institut

Forschungsstrasse 111
5232 Villigen PSI
Switzerland

Telephone: +41 56 310 21 11
Telefax: +41 56 310 21 99

How to find us
Contact

Visitor Centre psi forum
School Lab iLab (in German)
Center for Proton Therapy
PSI Education Centre
PSI Guest House
PSI Gastronomie (in German)
psi forum shop

Service & Support

  • Phone Book
  • User Office
  • Accelerator Status
  • PSI Publications
  • Suppliers
  • E-Billing
  • Computing
  • Safety (in German)

Career

  • Working at PSI
  • Job Opportunities
  • Training and further education
  • Vocational Training (in German)
  • PSI Education Center

For the media

  • PSI in brief
  • Facts and Figures
  • Media corner
  • Media Releases
  • Social Media

Follow us: Twitter (in English) LinkedIn Youtube Facebook Instagram Issuu RSS

Footer legal

  • Imprint
  • Terms and Conditions
  • Editors' login